Clinical Research Directory
Browse clinical research sites, groups, and studies.
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
Sponsor: Axsome Therapeutics, Inc.
Summary
ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol for the treatment of binge eating disorder (BED) in adults.
Official title: A Phase 3, Randomized, Double-blind, Placebo-Controlled Trial of Solriamfetol in Adults With Binge Eating Disorder (BED)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
450
Start Date
2024-04-26
Completion Date
2025-12
Last Updated
2025-11-21
Healthy Volunteers
No
Conditions
Interventions
Solriamfetol 150 mg
Solriamfetol tablets, taken once daily
Solriamfetol 300 mg
Solriamfetol tablets, taken once daily
Placebo
Placebo tablets, taken once daily
Locations (45)
Clinical Research Site
Encino, California, United States
Clinical Research Site
Garden Grove, California, United States
Clinical Research Site
Long Beach, California, United States
Clinical Research Site
Newport Beach, California, United States
Clinical Research Site
San Diego, California, United States
Clinical Research Site
Santa Ana, California, United States
Clinical Research Site
Walnut Creek, California, United States
Clinical Research Site
West Covina, California, United States
Clinical Research Site
Colorado Springs, Colorado, United States
Clinical Research Site
Cromwell, Connecticut, United States
Clinical Research Site
Clermont, Florida, United States
Clinical Research Site
Fort Myers, Florida, United States
Clinical Research Site
Hialeah, Florida, United States
Clinical Research Site
Jacksonville, Florida, United States
Clinical Research Site
Lauderhill, Florida, United States
Clinical Research Site
Miami, Florida, United States
Clinical Research Site
Miami, Florida, United States
Clinical Research Site
Miami Lakes, Florida, United States
Clinical Research Site
Orlando, Florida, United States
Clinical Research Site
Orlando, Florida, United States
Clinical Research Site
Marietta, Georgia, United States
Clinical Research Site
Overland Park, Kansas, United States
Clinical Research Site
Boston, Massachusetts, United States
Clinical Research Site
Methuen, Massachusetts, United States
Clinical Research Site
Saint Charles, Missouri, United States
Clinical Research Site
Cherry Hill, New Jersey, United States
Clinical Research Site
Princeton, New Jersey, United States
Clinical Research Site
Mount Kisco, New York, United States
Clinical Research Site
New York, New York, United States
Clinical Research Site
Raleigh, North Carolina, United States
Clinical Research Site
Cincinnati, Ohio, United States
Clinical Research Site
Mason, Ohio, United States
Clinical Research Site
Middleburg Heights, Ohio, United States
Clinical Research Site
North Canton, Ohio, United States
Clinical Research Site
Portland, Oregon, United States
Clinical Research Site
Allentown, Pennsylvania, United States
Clinical Research Site
Media, Pennsylvania, United States
Clinical Research Site
Greenville, South Carolina, United States
Clinical Research Site
North Charleston, South Carolina, United States
Clinical Research Site
Memphis, Tennessee, United States
Clinical Research Site
Austin, Texas, United States
Clinical Research Site
Austin, Texas, United States
Clinical Research Site
Dallas, Texas, United States
Clinical Research Site
San Antonio, Texas, United States
Clinical Research Site
Draper, Utah, United States